Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1987 Jul;31(7):978–981. doi: 10.1128/aac.31.7.978

Pentamidine aerosol in prophylaxis and treatment of murine Pneumocystis carinii pneumonia.

P M Girard 1, M Brun-Pascaud 1, R Farinotti 1, L Tamisier 1, S Kernbaum 1
PMCID: PMC174855  PMID: 3499116

Abstract

The efficacy and tolerance of pentamidine aerosol were evaluated in the prophylaxis and therapy of murine Pneumocystis carinii pneumonia. P. carinii pneumonia was induced in rats by corticosteroid immunosuppression. Pentamidine was administered three times weekly via a Bird micronebulizer. The actual amount of pentamidine inhaled was estimated by monitoring the ventilation of the rats during the aerosol administration. Pentamidine levels in blood, lung, liver and kidney samples were determined by high-pressure liquid chromatography after completion of the treatment. Efficacy was evaluated by examination of lung imprints. In the prophylactic treatment, 4.8- and 8.6-mg/kg doses of aerosolized pentamidine administered three times weekly for 7 weeks were effective in preventing P. carinii pneumonia in 80 and 100% of the rats, respectively. In the therapeutic studies, a 14.6-mg/kg dose of aerosolized pentamidine administered three times weekly for 3 weeks was effective both in curing the pneumonia and in clearing P. carinii cysts in 70% of the rats. In the remaining animals, although the pneumonia was cured, the cysts persisted. A dose-dependent effect of the drug was demonstrated in both prophylactic and therapeutic treatments. High lung/kidney and lung/liver ratios of pentamidine levels were demonstrated and were associated with good clinical, biological, and histologic tolerance.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Berendt R. F., Long G. G., Walker J. S. Treatment of respiratory Klebsiella pneumoniae infection in mice with aerosols of kanamycin. Antimicrob Agents Chemother. 1975 Nov;8(5):585–590. doi: 10.1128/aac.8.5.585. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bernard E. M., Donnelly H. J., Maher M. P., Armstrong D. Use of a new bioassay to study pentamidine pharmacokinetics. J Infect Dis. 1985 Oct;152(4):750–754. doi: 10.1093/infdis/152.4.750. [DOI] [PubMed] [Google Scholar]
  3. Buchdahl R. M., Taylor P., Warner J. D. Nebulised ribavirin for adenovirus pneumonia. Lancet. 1985 Nov 9;2(8463):1070–1071. doi: 10.1016/s0140-6736(85)90941-9. [DOI] [PubMed] [Google Scholar]
  4. Coggins C. R., Duchosal F., Musy C., Ventrone R. Measurement of respiratory patterns in rodents using whole-body plethysmography and a pneumotachograph. Lab Anim. 1981 Apr;15(2):137–140. doi: 10.1258/002367781780959125. [DOI] [PubMed] [Google Scholar]
  5. Cushion M. T., Stanforth D., Linke M. J., Walzer P. D. Method of testing the susceptibility of Pneumocystis carinii to antimicrobial agents in vitro. Antimicrob Agents Chemother. 1985 Dec;28(6):796–801. doi: 10.1128/aac.28.6.796. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Debs R. J., Blumenfeld W., Brunette E. N., Straubinger R. M., Montgomery A. B., Lin E., Agabian N., Papahadjopoulos D. Successful treatment with aerosolized pentamidine of Pneumocystis carinii pneumonia in rats. Antimicrob Agents Chemother. 1987 Jan;31(1):37–41. doi: 10.1128/aac.31.1.37. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Fitzgeorge R. B., Baskerville A., Featherstone A. S. Treatment of experimental Legionnaires' disease by aerosol administration of rifampicin, ciprofloxacin, and erythromycin. Lancet. 1986 Mar 1;1(8479):502–503. doi: 10.1016/s0140-6736(86)92960-0. [DOI] [PubMed] [Google Scholar]
  8. Frenkel J. K., Good J. T., Shultz J. A. Latent Pneumocystis infection of rats, relapse, and chemotherapy. Lab Invest. 1966 Oct;15(10):1559–1577. [PubMed] [Google Scholar]
  9. Hall C. B., McBride J. T., Walsh E. E., Bell D. M., Gala C. L., Hildreth S., Ten Eyck L. G., Hall W. J. Aerosolized ribavirin treatment of infants with respiratory syncytial viral infection. A randomized double-blind study. N Engl J Med. 1983 Jun 16;308(24):1443–1447. doi: 10.1056/NEJM198306163082403. [DOI] [PubMed] [Google Scholar]
  10. Hughes W. T., McNabb P. C., Makres T. D., Feldman S. Efficacy of trimethoprim and sulfamethoxazole in the prevention and treatment of Pneumocystis carinii pneumonitis. Antimicrob Agents Chemother. 1974 Mar;5(3):289–293. doi: 10.1128/aac.5.3.289. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Hughes W. T., Smith B. L. Efficacy of diaminodiphenylsulfone and other drugs in murine Pneumocystis carinii pneumonitis. Antimicrob Agents Chemother. 1984 Oct;26(4):436–440. doi: 10.1128/aac.26.4.436. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Kernbaum S., Masliah J., Alcindor L. G., Bouton C., Christol D. Phospholipase activities of bronchoalveolar lavage fluid in rat Pneumocystis carinii pneumonia. Br J Exp Pathol. 1983 Feb;64(1):75–80. [PMC free article] [PubMed] [Google Scholar]
  13. Waalkes T. P., DeVita V. T. he determination of pentamidine (4,4'-diamidinophenoxypentane) in plasma, urine, and tissues. J Lab Clin Med. 1970 May;75(5):871–878. [PubMed] [Google Scholar]
  14. Western K. A., Norman L., Kaufmann A. G. Failure of pentamidine isethionate to provide chemoprophylaxis against Pneumocytis carinii infection in rats. J Infect Dis. 1975 Mar;131(3):273–276. doi: 10.1093/infdis/131.3.273. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES